STI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
STI is not a good buy right now. The stock just sold off hard (-8.74% regular session) and is sitting near support with weakening momentum (MACD negative and worsening). With no bullish proprietary signals, no supportive news catalysts, and deteriorating profitability in the latest quarter (2025/Q3), the risk/reward is unfavorable for an impatient buyer looking to enter immediately.
Trend/Momentum: Bearish-to-weak. The MACD histogram is -0.0114 (below zero) and negatively expanding, signaling downside momentum is strengthening. RSI(6) at 37.94 is not deeply oversold, implying downside can continue without a technical “snap-back” requirement. Moving averages are converging, which typically indicates indecision/transition, but combined with today’s sharp drop it leans bearish. Key Levels: Price is ~7.31 post-market, essentially on S1 support (7.303). A clean break below S1 increases downside risk toward S2 (6.677). Overhead resistance sits at Pivot 8.315, then R1 9.327. Pattern-based forward stats: Similar-pattern analysis suggests only modest upside expectations (+0.76% next day, +1.35% next week, +0.5% next month) with a 60% probability, which is not compelling given current downside momentum.
Intellectia Proprietary Trading Signals
Upcoming earnings event on 2026-02-19 (pre-market) could act as a catalyst if results or guidance surprise positively. Price is sitting right on first support (S1 ~7.303), which sometimes produces a short-term technical bounce.
fails, the next notable downside level is ~6.677 (S2). No recent news flow to reverse sentiment. Profitability deterioration in 2025/Q3 (larger net loss and worse EPS) undermines confidence ahead of the next earnings catalyst.
Latest quarter: 2025/Q3. Revenue increased to 9,350 (0.00% YoY, effectively flat). Net income dropped to -4,092,145 (down -38.34% YoY, loss widened). EPS dropped to -1.33 (down -60.18% YoY). Gross margin increased to 53.79 (0.00% YoY). Overall: margins look stable/high, but the key trend is worsening bottom-line performance and EPS deterioration, which is a negative setup for a near-term buy.
No analyst rating or price target change data was provided, so Wall Street pro/con positioning cannot be verified from the dataset. Trading sentiment indicators show hedge funds neutral (no significant last-quarter trend) and insiders neutral (no significant last-month trend). Politicians/influential figures: No recent congress trading data available.
